The search for more effective diagnostic methods has never been more important - particularly in the detection of latent TB.

Geiter L, "Ending Neglect:  The elimination of Tuberculosis in the United States", 1st ed., Washington DC:  National Academy Press 2000.

Product Overview

T-Sppot.TB logo

 

The T-SPOT®.TB test is a blood test for the diagnosis of active and latent TB infection that enumerates the response of effector T cells that have been sensitized to Mycobacterium tuberculosis.  

The T-SPOT.TB test is the only blood test that has demonstrated in a pivotal clinical study both sensitivity and specificity exceeding ninety-five percent and reliability in all targeted testing groups.   

The T-SPOT.TB test addresses the unique requirements of all groups tested for TB:  

Accurate: The only TB test with sensitivity and specificity exceeding 95% in pivotal clinical trials.

Reliable: Even in challenging testing populations, including foreign-born and immunosuppressed.

Simple: One visit, one tube.

Saves money: Hundreds of institutions have already seen how.

Covered by most insurance: CPT code 86481.


 

 

 

 

The T-SPOT.TB Test Kit

  • Flexible 96-well format
    • Twelve, 8-well strips
    • Four wells used per patient, 24 patients per kit
    • Positive and Negative control for each patient test
    • A minimum of 1 patient test can be run
  • Utilizes standard blood collection tubes
  • No special lab equipment required

 

¹T-SPOT.TB Pivotal Clinical Study.  Sensitivity of 95.6%.  Specificity of 97.1%.  T-SPOT.TB Package Insert.

²T-SPOT.TB Pivotal Clinical Study.  T-SPOT.TB results were not associated with immunocompromised status or BCG vaccination.  T-SPOT.TB was not impacted by age.  T-SPOT.TB Package Insert.